Ignite Creation Date:
2024-05-06 @ 4:34 PM
Last Modification Date:
2024-10-26 @ 2:12 PM
Study NCT ID:
NCT05028348
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-07-03
First Post:
2021-08-25
Brief Title:
A Study of Combination of Selinexor Pomalidomide and Dexamethasone SPd Versus Elotuzumab Pomalidomide and Dexamethasone EloPd in Subject With Previously Treated Multiple Myeloma
Sponsor:
Stichting European Myeloma Network
Organization:
Stichting European Myeloma Network
Organization Data
Organization:
Stichting European Myeloma Network
Class:
NETWORK
Study ID:
EMN29
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Stichting European Myeloma Network
Lead Sponsor Class:
NETWORK
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Karyopharm Therapeutics Inc | INDUSTRY |